Please login to the form below

Not currently logged in
Email:
Password:

Calico

This page shows the latest Calico news and features for those working in and with pharma, biotech and healthcare.

GSK to replace R&D head Vallance with Calico’s Hal Barron

GSK to replace R&D head Vallance with Calico’s Hal Barron

GSK to replace R&D head Vallance with Calico’ s Hal Barron. ... His current role at Calico, funded by Google parent Alphabet, has concentrated on understanding processes involved in ageing and the move to GSK reflects a return to his traditional

Latest news

More from news
Approximately 4 fully matching, plus 12 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Levinson resigns from Roche board Levinson resigns from Roche board

    Levinson resigns from Roche board. Declares conflict of interest due to his position as CEO at Calico. ... Arthur Levinson has resigned from Roche's board of directors due to conflict of interest issues related to his position as CEO of Calico.

  • Roche CMO joins Google health venture Calico Roche CMO joins Google health venture Calico

    Roche CMO joins Google health venture Calico. Hal Barron among four new appointments. ... The other new recruit is Dr Cynthia Kenyon who joins Calico as senior scientific adviser.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • What pharma needs to know about genomic data in 2016

    and  Calico, who are leveraging this multi-discipline approach to target the single biggest risk factor in all human disease – ageing. ... HLI), Calico, 23andme, and the mean that we’ ll start to see some innovative research and development work

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashley Communications

Ashley Communications is a bespoke, independent medical communications consultancy consistently providing a unique director-delivered client service tailored to individual client...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics